Stocktoria
Elevance Health, Inc. ELV
Elevance Health, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($333.45); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Elevance Health, Inc. trades at about 15.8× earnings — near its 10-year norm (10-year range 13.7×–21.4×, median 17.3×).
Shaded band = 10-year range (13.7×–21.4×); dot = today's 15.8×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 3.6% | 4.4% | 5.0% | 5.3% | 5.5% | 5.2% | 5.8% | 5.9% | 4.6% | 5.7% |
| Net margin | 2.8% | 3.4% | 3.5% | 3.8% | 4.4% | 3.8% | 4.6% | 4.1% | 4.3% | 2.9% |
| FCF margin | 1.6% | 2.6% | 3.9% | 4.6% | 5.2% | 7.9% | 4.8% | 2.8% | 3.8% | 3.2% |
| Return on assets | 4.7% | 5.1% | 5.5% | 5.7% | 6.3% | 5.3% | 6.2% | 5.2% | 5.4% | 3.8% |
| Return on equity | 12.9% | 14.4% | 15.2% | 16.2% | 17.0% | 13.8% | 15.2% | 13.1% | 14.5% | 9.8% |
| Debt / equity | 0.72× | 0.75× | 0.63× | 0.66× | 0.63× | 0.60× | 0.61× | 0.63× | 0.70× | 0.61× |
| Current ratio | 1.54 | 1.45 | 1.44 | 1.40 | 1.47 | 1.55 | 1.66 | 1.56 | 1.55 | 1.61 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.